Header Logo

Connection

David Bennett to Brain

Back to Details
This is a "connection" page, showing publications David Bennett has written about Brain.
David Bennett
Connection Strength
26.141
Brain
  1. Microglial Correlates of Late Life Physical Activity: Relationship with Synaptic and Cognitive Aging in Older Adults. J Neurosci. 2022 01 12; 42(2):288-298.
    View in: PubMed
    Score: 0.394
  2. Brain pathologies are associated with both the rate and variability of declining motor function in older adults. Acta Neuropathol. 2020 10; 140(4):587-589.
    View in: PubMed
    Score: 0.361
  3. What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications? AIDS Res Hum Retroviruses. 2021 04; 37(4):255-265.
    View in: PubMed
    Score: 0.360
  4. Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults. Transl Psychiatry. 2019 10 03; 9(1):241.
    View in: PubMed
    Score: 0.340
  5. Gene expression and DNA methylation are extensively coordinated with MRI-based brain microstructural characteristics. Brain Imaging Behav. 2019 Aug; 13(4):963-972.
    View in: PubMed
    Score: 0.336
  6. Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline. Neurobiol Aging. 2019 12; 84:17-25.
    View in: PubMed
    Score: 0.335
  7. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology. 2019 04 16; 92(16):e1821-e1830.
    View in: PubMed
    Score: 0.327
  8. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019 02 19; 92(8):e811-e822.
    View in: PubMed
    Score: 0.323
  9. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.318
  10. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.311
  11. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.308
  12. Brain pathology is related to total daily physical activity in older adults. Neurology. 2018 05 22; 90(21):e1911-e1919.
    View in: PubMed
    Score: 0.307
  13. Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
    View in: PubMed
    Score: 0.299
  14. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.290
  15. Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery. PLoS Med. 2017 Mar; 14(3):e1002256.
    View in: PubMed
    Score: 0.284
  16. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.284
  17. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.274
  18. Cognitive activity, cognitive function, and brain diffusion characteristics in old age. Brain Imaging Behav. 2016 06; 10(2):455-63.
    View in: PubMed
    Score: 0.269
  19. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016 Feb; 30(2):135-42.
    View in: PubMed
    Score: 0.263
  20. Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology. 2016 Feb 23; 86(8):735-41.
    View in: PubMed
    Score: 0.263
  21. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.257
  22. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol. 2015 Oct; 67:58-64.
    View in: PubMed
    Score: 0.251
  23. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.249
  24. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016 05; 221(4):2135-46.
    View in: PubMed
    Score: 0.248
  25. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
    View in: PubMed
    Score: 0.244
  26. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.243
  27. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
    View in: PubMed
    Score: 0.238
  28. Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathol. 2014 Jan; 127(1):137-50.
    View in: PubMed
    Score: 0.227
  29. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.224
  30. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.224
  31. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One. 2013; 8(8):e73107.
    View in: PubMed
    Score: 0.222
  32. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct. 2014 Nov; 219(6):2029-49.
    View in: PubMed
    Score: 0.222
  33. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.220
  34. Microvascular brain pathology and late-life motor impairment. Neurology. 2013 Feb 19; 80(8):712-8.
    View in: PubMed
    Score: 0.214
  35. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.213
  36. Functional connectivity networks associated with chronic musculoskeletal pain in old age. Int J Geriatr Psychiatry. 2013 Aug; 28(8):858-67.
    View in: PubMed
    Score: 0.210
  37. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.205
  38. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry. 2012 May 15; 2:e114.
    View in: PubMed
    Score: 0.204
  39. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.203
  40. Terminal dedifferentiation of cognitive abilities. Neurology. 2012 Apr 10; 78(15):1116-22.
    View in: PubMed
    Score: 0.202
  41. Neural intrinsic connectivity networks associated with risk aversion in old age. Behav Brain Res. 2012 Feb 01; 227(1):233-40.
    View in: PubMed
    Score: 0.196
  42. Functional connectivity variations in mild cognitive impairment: associations with cognitive function. J Int Neuropsychol Soc. 2012 Jan; 18(1):39-48.
    View in: PubMed
    Score: 0.196
  43. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.188
  44. Where vascular meets neurodegenerative disease. Stroke. 2010 Oct; 41(10 Suppl):S144-6.
    View in: PubMed
    Score: 0.182
  45. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.181
  46. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.168
  47. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.168
  48. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.165
  49. NSAID exposure and risk of Alzheimer disease: is timing everything? Neurology. 2009 Jun 02; 72(22):1884-5.
    View in: PubMed
    Score: 0.165
  50. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008 Aug 12; 71(7):499-504.
    View in: PubMed
    Score: 0.157
  51. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.151
  52. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007 Dec 11; 69(24):2197-204.
    View in: PubMed
    Score: 0.145
  53. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3 Suppl 2):S63-8.
    View in: PubMed
    Score: 0.135
  54. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.126
  55. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.124
  56. High resolution 0.5mm isotropic T1-weighted and diffusion tensor templates of the brain of non-demented older adults in a common space for the MIITRA atlas. Neuroimage. 2023 11 15; 282:120387.
    View in: PubMed
    Score: 0.112
  57. Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023 08; 94(2):232-244.
    View in: PubMed
    Score: 0.109
  58. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023 04 01; 80(4):370-376.
    View in: PubMed
    Score: 0.108
  59. Proteome-Wide Discovery of Cortical Proteins That May Provide Motor Resilience to Offset the Negative Effects of Pathologies in Older Adults. J Gerontol A Biol Sci Med Sci. 2023 03 01; 78(3):494-503.
    View in: PubMed
    Score: 0.108
  60. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.107
  61. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.107
  62. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.107
  63. A Qualitative Examination of Knowledge, Experiences, and Considerations of PET Brain Scan Participation Among Older Black and Latino Adults. J Alzheimers Dis. 2023; 91(3):961-976.
    View in: PubMed
    Score: 0.106
  64. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment. JAMA Neurol. 2022 12 01; 79(12):1277-1286.
    View in: PubMed
    Score: 0.106
  65. Association of AK4 Protein From Stem Cell-Derived Neurons With Cognitive Reserve: An Autopsy Study. Neurology. 2022 11 15; 99(20):e2264-e2274.
    View in: PubMed
    Score: 0.103
  66. Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia. J Gerontol A Biol Sci Med Sci. 2022 04 01; 77(4):664-672.
    View in: PubMed
    Score: 0.101
  67. Late-life physical activity relates to brain tissue synaptic integrity markers in older adults. Alzheimers Dement. 2022 11; 18(11):2023-2035.
    View in: PubMed
    Score: 0.099
  68. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias. Neurology. 2022 03 08; 98(10):e1031-e1039.
    View in: PubMed
    Score: 0.099
  69. Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging. JAMA Neurol. 2021 12 01; 78(12):1494-1502.
    View in: PubMed
    Score: 0.099
  70. Associations of deformation-based brain morphometry with cognitive level and decline within older Blacks without dementia. Neurobiol Aging. 2022 03; 111:35-43.
    View in: PubMed
    Score: 0.098
  71. Reducing Your Risk of Alzheimer's Dementia: Building a Better Brain as We Age. Arch Clin Neuropsychol. 2021 Oct 13; 36(7):1257-1265.
    View in: PubMed
    Score: 0.098
  72. Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline. Stroke. 2022 01; 53(1):218-227.
    View in: PubMed
    Score: 0.098
  73. Influence of Cognitive Reserve on Cognitive Trajectories: Role of Brain Pathologies. Neurology. 2021 10 26; 97(17):e1695-e1706.
    View in: PubMed
    Score: 0.097
  74. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.097
  75. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021 07 27; 9(1):129.
    View in: PubMed
    Score: 0.096
  76. Association of cardiovascular risk burden with risk of dementia and brain pathologies: A population-based cohort study. Alzheimers Dement. 2021 12; 17(12):1914-1922.
    View in: PubMed
    Score: 0.096
  77. Physical activity, brain tissue microstructure, and cognition in older adults. PLoS One. 2021; 16(7):e0253484.
    View in: PubMed
    Score: 0.096
  78. Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition. J Neuroinflammation. 2021 Jul 04; 18(1):147.
    View in: PubMed
    Score: 0.096
  79. The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes. Neurobiol Dis. 2021 09; 157:105428.
    View in: PubMed
    Score: 0.096
  80. The "cognitive clock": A novel indicator of brain health. Alzheimers Dement. 2021 12; 17(12):1923-1937.
    View in: PubMed
    Score: 0.095
  81. Brain insulin signaling and cerebrovascular disease in human postmortem brain. Acta Neuropathol Commun. 2021 04 15; 9(1):71.
    View in: PubMed
    Score: 0.094
  82. Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies. Stroke. 2021 06; 52(6):2060-2067.
    View in: PubMed
    Score: 0.094
  83. Brain proteome-wide association study implicates novel proteins in depression pathogenesis. Nat Neurosci. 2021 06; 24(6):810-817.
    View in: PubMed
    Score: 0.094
  84. Person-Specific Contributions of Brain Pathologies to Progressive Parkinsonism in Older Adults. J Gerontol A Biol Sci Med Sci. 2021 03 31; 76(4):615-621.
    View in: PubMed
    Score: 0.094
  85. Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample. Acta Neuropathol. 2021 05; 141(5):755-770.
    View in: PubMed
    Score: 0.094
  86. Genetic control of the human brain proteome. Am J Hum Genet. 2021 03 04; 108(3):400-410.
    View in: PubMed
    Score: 0.093
  87. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. Nat Genet. 2021 02; 53(2):143-146.
    View in: PubMed
    Score: 0.093
  88. Development and evaluation of a high performance T1-weighted brain template for use in studies on older adults. Hum Brain Mapp. 2021 04 15; 42(6):1758-1776.
    View in: PubMed
    Score: 0.093
  89. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.093
  90. Association of Amyloid-? Pathology with Decision Making and Scam Susceptibility. J Alzheimers Dis. 2021; 83(2):879-887.
    View in: PubMed
    Score: 0.093
  91. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. JAMA Neurol. 2020 10 01; 77(10):1288-1298.
    View in: PubMed
    Score: 0.091
  92. Deconvolving the contributions of cell-type heterogeneity on cortical gene expression. PLoS Comput Biol. 2020 08; 16(8):e1008120.
    View in: PubMed
    Score: 0.090
  93. Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults. Stroke. 2020 09; 51(9):2825-2833.
    View in: PubMed
    Score: 0.090
  94. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.090
  95. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.090
  96. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Rep. 2020 07 14; 32(2):107908.
    View in: PubMed
    Score: 0.090
  97. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.089
  98. Total daily physical activity, brain pathologies, and parkinsonism in older adults. PLoS One. 2020; 15(4):e0232404.
    View in: PubMed
    Score: 0.088
  99. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.088
  100. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.088
  101. The Health Equity Through Aging Research And Discussion (HEARD) Study: A Proposed Two-Phase Sequential Mixed-Methods Research Design To Understand Barriers And Facilitators Of Brain Donation Among Diverse Older Adults. Exp Aging Res. 2020 Jul-Sep; 46(4):311-322.
    View in: PubMed
    Score: 0.088
  102. Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. Neuron. 2020 03 18; 105(6):1027-1035.e2.
    View in: PubMed
    Score: 0.087
  103. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.086
  104. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis. Neurobiol Aging. 2020 02; 86:123-133.
    View in: PubMed
    Score: 0.085
  105. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 11; 51(11):1624-1636.
    View in: PubMed
    Score: 0.085
  106. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.085
  107. Common age-related neuropathologies and yearly variability in cognition. Ann Clin Transl Neurol. 2019 11; 6(11):2140-2149.
    View in: PubMed
    Score: 0.085
  108. Interaction between the progression of Alzheimer's disease and fractal degradation. Neurobiol Aging. 2019 11; 83:21-30.
    View in: PubMed
    Score: 0.084
  109. Using Transcriptomic Hidden Variables to Infer Context-Specific Genotype Effects in the Brain. Am J Hum Genet. 2019 09 05; 105(3):562-572.
    View in: PubMed
    Score: 0.084
  110. Insulin and adipokine signaling and their cross-regulation in postmortem human brain. Neurobiol Aging. 2019 12; 84:119-130.
    View in: PubMed
    Score: 0.084
  111. Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer's Disease. Cell Rep. 2019 07 23; 28(4):1103-1116.e4.
    View in: PubMed
    Score: 0.084
  112. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.083
  113. Rate of brain aging and APOE e4 are synergistic risk factors for Alzheimer's disease. Life Sci Alliance. 2019 06; 2(3).
    View in: PubMed
    Score: 0.083
  114. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.082
  115. Education and cognitive reserve in old age. Neurology. 2019 03 05; 92(10):e1041-e1050.
    View in: PubMed
    Score: 0.081
  116. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.081
  117. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. 2019 02 12; 92(7):e700-e709.
    View in: PubMed
    Score: 0.081
  118. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.080
  119. Spinal motor neurons and motor function in older adults. J Neurol. 2019 Jan; 266(1):174-182.
    View in: PubMed
    Score: 0.080
  120. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility. Nat Genet. 2018 11; 50(11):1584-1592.
    View in: PubMed
    Score: 0.079
  121. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.078
  122. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.078
  123. Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults. Neurobiol Aging. 2018 09; 69:177-184.
    View in: PubMed
    Score: 0.077
  124. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.075
  125. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol. 2018 01; 135(1):85-93.
    View in: PubMed
    Score: 0.075
  126. Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease. Mov Disord. 2017 Dec; 32(12):1729-1737.
    View in: PubMed
    Score: 0.074
  127. Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism. Stroke. 2017 10; 48(10):2792-2798.
    View in: PubMed
    Score: 0.074
  128. An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome. Nat Neurosci. 2017 Oct; 20(10):1418-1426.
    View in: PubMed
    Score: 0.073
  129. Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain. Transl Psychiatry. 2017 08 08; 7(8):e1199.
    View in: PubMed
    Score: 0.073
  130. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.072
  131. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology. 2017 Feb 14; 88(7):653-660.
    View in: PubMed
    Score: 0.070
  132. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology. J Alzheimers Dis. 2017; 56(4):1485-1493.
    View in: PubMed
    Score: 0.070
  133. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia?attributable to pathology-confirmed vascular disease. Alzheimers Dement. 2017 Jun; 13(6):613-623.
    View in: PubMed
    Score: 0.070
  134. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.070
  135. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
    View in: PubMed
    Score: 0.069
  136. Differential transcriptome expression in human nucleus accumbens as a function of loneliness. Mol Psychiatry. 2017 07; 22(7):1069-1078.
    View in: PubMed
    Score: 0.069
  137. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.069
  138. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol. 2016 10; 132(4):503-14.
    View in: PubMed
    Score: 0.069
  139. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47.
    View in: PubMed
    Score: 0.068
  140. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
    View in: PubMed
    Score: 0.067
  141. Grey matter correlates of susceptibility to scams in community-dwelling older adults. Brain Imaging Behav. 2016 06; 10(2):524-32.
    View in: PubMed
    Score: 0.067
  142. Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016 05 26; 533(7604):539-42.
    View in: PubMed
    Score: 0.067
  143. Financial literacy is associated with white matter integrity in old age. Neuroimage. 2016 Apr 15; 130:223-229.
    View in: PubMed
    Score: 0.066
  144. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.066
  145. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.065
  146. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol. 2016 10; 53(8):5066-78.
    View in: PubMed
    Score: 0.064
  147. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.064
  148. GSK3? Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res. 2015 Oct; 28(3):232-8.
    View in: PubMed
    Score: 0.063
  149. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.063
  150. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
    View in: PubMed
    Score: 0.063
  151. a-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015 Jul; 78(1):142-9.
    View in: PubMed
    Score: 0.063
  152. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015 Apr; 36(4):1765.e7-1765.e16.
    View in: PubMed
    Score: 0.061
  153. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep; 17(9):1156-63.
    View in: PubMed
    Score: 0.059
  154. Epigenomics of Alzheimer's disease. Transl Res. 2015 Jan; 165(1):200-20.
    View in: PubMed
    Score: 0.058
  155. White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia. 1994 May-Aug; 5(3-4):148-52.
    View in: PubMed
    Score: 0.058
  156. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.058
  157. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement. 2015 Jan; 11(1):32-9.
    View in: PubMed
    Score: 0.058
  158. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.057
  159. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.056
  160. The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan. Mol Psychiatry. 2014 Oct; 19(10):1125-32.
    View in: PubMed
    Score: 0.056
  161. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.056
  162. Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol. 2013 Sep; 72(9):824-32.
    View in: PubMed
    Score: 0.056
  163. Very low levels of education and cognitive reserve: a clinicopathologic study. Neurology. 2013 Aug 13; 81(7):650-7.
    View in: PubMed
    Score: 0.055
  164. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013 Apr 25; 153(3):707-20.
    View in: PubMed
    Score: 0.054
  165. Ex vivo MR volumetry of human brain hemispheres. Magn Reson Med. 2014 Jan; 71(1):364-74.
    View in: PubMed
    Score: 0.054
  166. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.052
  167. The natural history of cognitive decline in Alzheimer's disease. Psychol Aging. 2012 Dec; 27(4):1008-17.
    View in: PubMed
    Score: 0.052
  168. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.051
  169. Terminal decline in motor function. Psychol Aging. 2012 Dec; 27(4):998-1007.
    View in: PubMed
    Score: 0.051
  170. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.051
  171. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.050
  172. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol. 1992 Apr; 239(4):186-90.
    View in: PubMed
    Score: 0.050
  173. Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults. J Gerontol A Biol Sci Med Sci. 2012 Sep; 67(9):957-62.
    View in: PubMed
    Score: 0.050
  174. Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 28(2):433-41.
    View in: PubMed
    Score: 0.050
  175. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.050
  176. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 29(3):691-7.
    View in: PubMed
    Score: 0.050
  177. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011 Sep; 70(9):788-98.
    View in: PubMed
    Score: 0.048
  178. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke. 2011 Nov; 42(11):3183-9.
    View in: PubMed
    Score: 0.048
  179. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608.
    View in: PubMed
    Score: 0.048
  180. Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. Curr Alzheimer Res. 2011 Jun; 8(4):336-40.
    View in: PubMed
    Score: 0.048
  181. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain. Synapse. 2011 Aug; 65(8):763-70.
    View in: PubMed
    Score: 0.047
  182. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.047
  183. Lewy bodies and olfactory dysfunction in old age. Chem Senses. 2011 May; 36(4):367-73.
    View in: PubMed
    Score: 0.046
  184. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.046
  185. Loss of basic lexical knowledge in old age. J Neurol Neurosurg Psychiatry. 2011 Apr; 82(4):369-72.
    View in: PubMed
    Score: 0.045
  186. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol. 2010 Apr; 67(4):475-82.
    View in: PubMed
    Score: 0.044
  187. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.042
  188. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn Reson Med. 2009 Apr; 61(4):810-8.
    View in: PubMed
    Score: 0.041
  189. Age-associated reduction of asymmetry in prefrontal function and preservation of conceptual repetition priming. Neuroimage. 2009 Mar 01; 45(1):237-46.
    View in: PubMed
    Score: 0.040
  190. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet. 2008 Apr 01; 17(7):929-35.
    View in: PubMed
    Score: 0.037
  191. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.037
  192. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.037
  193. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.036
  194. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007 Feb; 64(2):234-40.
    View in: PubMed
    Score: 0.035
  195. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.035
  196. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007 Jan; 78(1):30-5.
    View in: PubMed
    Score: 0.034
  197. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging. 2006 Nov; 27(11):1644-57.
    View in: PubMed
    Score: 0.032
  198. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25(4):163-75.
    View in: PubMed
    Score: 0.032
  199. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.032
  200. Implicit memory and Alzheimer's disease neuropathology. Brain. 2005 Sep; 128(Pt 9):2006-15.
    View in: PubMed
    Score: 0.032
  201. Mild cognitive impairment: is it Alzheimer's disease or not? J Alzheimers Dis. 2005 Jun; 7(3):241-5; discussion 255-62.
    View in: PubMed
    Score: 0.031
  202. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.031
  203. Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology. 2005; 25(1):19-25.
    View in: PubMed
    Score: 0.031
  204. Microscale fractionation facilitates detection of differentially expressed proteins in Alzheimer's disease brain samples. Electrophoresis. 2004 Aug; 25(15):2557-63.
    View in: PubMed
    Score: 0.030
  205. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):211-9.
    View in: PubMed
    Score: 0.029
  206. Mild cognitive impairment. Clin Geriatr Med. 2004 Feb; 20(1):15-25.
    View in: PubMed
    Score: 0.029
  207. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.028
  208. Update on mild cognitive impairment. Curr Neurol Neurosci Rep. 2003 Sep; 3(5):379-84.
    View in: PubMed
    Score: 0.028
  209. Association of Motor Function With Cognitive Trajectories and Structural Brain Differences: A Community-Based Cohort Study. Neurology. 2023 10 24; 101(17):e1718-e1728.
    View in: PubMed
    Score: 0.028
  210. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.028
  211. The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy. Am J Geriatr Psychiatry. 2023 12; 31(12):1129-1139.
    View in: PubMed
    Score: 0.028
  212. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003 Jun 24; 60(12):1909-15.
    View in: PubMed
    Score: 0.027
  213. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.027
  214. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003 Apr 08; 60(7):1082-8.
    View in: PubMed
    Score: 0.027
  215. Neurodegenerative and Cerebrovascular Brain Pathologies Are Differentially Associated With Declining Grip Strength and Gait In Older Adults. J Gerontol A Biol Sci Med Sci. 2023 03 01; 78(3):504-513.
    View in: PubMed
    Score: 0.027
  216. Predicting age at Alzheimer's dementia onset with the cognitive clock. Alzheimers Dement. 2023 08; 19(8):3555-3562.
    View in: PubMed
    Score: 0.027
  217. Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease. Neurobiol Aging. 2023 06; 126:25-33.
    View in: PubMed
    Score: 0.027
  218. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults. JAMA Neurol. 2023 01 01; 80(1):49-57.
    View in: PubMed
    Score: 0.027
  219. Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study. J Alzheimers Dis. 2023; 95(4):1585-1595.
    View in: PubMed
    Score: 0.027
  220. Well-Being and Cognitive Resilience to Dementia-Related Neuropathology. Psychol Sci. 2023 03; 34(3):283-297.
    View in: PubMed
    Score: 0.026
  221. Brain and spinal cord arteriolosclerosis and its associations with cerebrovascular disease risk factors in community-dwelling older adults. Acta Neuropathol. 2023 02; 145(2):219-233.
    View in: PubMed
    Score: 0.026
  222. The Caribbean-Hispanic Alzheimer's disease brain transcriptome reveals ancestry-specific disease mechanisms. Neurobiol Dis. 2023 01; 176:105938.
    View in: PubMed
    Score: 0.026
  223. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.026
  224. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.026
  225. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.026
  226. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.026
  227. Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease. Aging (Albany NY). 2022 07 30; 14(14):5641-5668.
    View in: PubMed
    Score: 0.026
  228. Development of high quality T1-weighted and diffusion tensor templates of the older adult brain in a common space. Neuroimage. 2022 10 15; 260:119417.
    View in: PubMed
    Score: 0.026
  229. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.026
  230. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging. 2022 09; 117:128-138.
    View in: PubMed
    Score: 0.026
  231. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.025
  232. Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults. Neurology. 2022 05 10; 98(19):e1976-e1984.
    View in: PubMed
    Score: 0.025
  233. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology. 2022 03 29; 98(13):e1304-e1314.
    View in: PubMed
    Score: 0.025
  234. Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study. Alzheimers Dement. 2022 12; 18(12):2551-2559.
    View in: PubMed
    Score: 0.025
  235. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):30.
    View in: PubMed
    Score: 0.025
  236. Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks. Nat Commun. 2022 02 03; 13(1):655.
    View in: PubMed
    Score: 0.025
  237. Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022 02; 25(2):213-225.
    View in: PubMed
    Score: 0.025
  238. Brain microRNAs are associated with variation in cognitive trajectory in advanced age. Transl Psychiatry. 2022 02 01; 12(1):47.
    View in: PubMed
    Score: 0.025
  239. Association of small vessel disease with tau pathology. Acta Neuropathol. 2022 03; 143(3):349-362.
    View in: PubMed
    Score: 0.025
  240. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.025
  241. Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. Alzheimers Dement. 2022 10; 18(10):1797-1811.
    View in: PubMed
    Score: 0.025
  242. Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. Nat Commun. 2021 12 02; 12(1):7035.
    View in: PubMed
    Score: 0.025
  243. Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain. Mol Neurodegener. 2021 11 06; 16(1):75.
    View in: PubMed
    Score: 0.025
  244. Pulmonary function is associated with cognitive decline and structural brain differences. Alzheimers Dement. 2022 07; 18(7):1335-1344.
    View in: PubMed
    Score: 0.024
  245. Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE e2 protective effect in Alzheimer disease. Mol Psychiatry. 2021 10; 26(10):6054-6064.
    View in: PubMed
    Score: 0.024
  246. Self-reported experiences of discrimination in older black adults are associated with insula functional connectivity. Brain Imaging Behav. 2021 Aug; 15(4):1718-1727.
    View in: PubMed
    Score: 0.024
  247. ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain. Neuroimage Clin. 2021; 31:102768.
    View in: PubMed
    Score: 0.024
  248. A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease. Nat Commun. 2021 07 22; 12(1):4472.
    View in: PubMed
    Score: 0.024
  249. Enhancing Top-Down Proteomics of Brain Tissue with FAIMS. J Proteome Res. 2021 05 07; 20(5):2780-2795.
    View in: PubMed
    Score: 0.024
  250. Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer's disease. Transl Psychiatry. 2021 02 24; 11(1):139.
    View in: PubMed
    Score: 0.023
  251. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 2021 05; 31(3):e12939.
    View in: PubMed
    Score: 0.023
  252. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.023
  253. Brain DNA Methylation Patterns in CLDN5 Associated With Cognitive Decline. Biol Psychiatry. 2022 02 15; 91(4):389-398.
    View in: PubMed
    Score: 0.023
  254. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.023
  255. EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE e4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. Alzheimers Dement. 2020 12; 16(Suppl 2).
    View in: PubMed
    Score: 0.023
  256. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem. 2000 Dec; 48(12):1627-38.
    View in: PubMed
    Score: 0.023
  257. Perceived Impediments to Completed Brain Autopsies Among Diverse Older Adults Who Have Signed a Uniform Anatomical Gift Act for Brain Donation for Clinical Research. Ethn Dis. 2020; 30(Suppl 2):709-718.
    View in: PubMed
    Score: 0.023
  258. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology. Neurobiol Dis. 2021 01; 148:105150.
    View in: PubMed
    Score: 0.023
  259. White matter correlates of scam susceptibility in community-dwelling older adults. Brain Imaging Behav. 2020 Oct; 14(5):1521-1530.
    View in: PubMed
    Score: 0.023
  260. Limbic-predominant Age-related TDP-43 Encephalopathy and Distinct Longitudinal Profiles of Domain-specific Literacy. Alzheimer Dis Assoc Disord. 2020 Oct-Dec; 34(4):299-305.
    View in: PubMed
    Score: 0.023
  261. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology. Mol Neurodegener. 2020 07 29; 15(1):44.
    View in: PubMed
    Score: 0.022
  262. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Mol Psychiatry. 2021 10; 26(10):6023-6037.
    View in: PubMed
    Score: 0.022
  263. Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline. J Am Coll Cardiol. 2020 05 26; 75(20):2525-2534.
    View in: PubMed
    Score: 0.022
  264. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.022
  265. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.022
  266. Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices. Alzheimers Dement. 2020 01; 16(1):209-218.
    View in: PubMed
    Score: 0.022
  267. Regulation of lifespan by neural excitation and REST. Nature. 2019 10; 574(7778):359-364.
    View in: PubMed
    Score: 0.021
  268. Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease. Cell Rep. 2019 10 08; 29(2):301-316.e10.
    View in: PubMed
    Score: 0.021
  269. Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
    View in: PubMed
    Score: 0.021
  270. Neuropsychological latent classes at enrollment and postmortem neuropathology. Alzheimers Dement. 2019 09; 15(9):1195-1207.
    View in: PubMed
    Score: 0.021
  271. Somatic mosaicism of sex chromosomes in the blood and brain. Brain Res. 2019 10 15; 1721:146345.
    View in: PubMed
    Score: 0.021
  272. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.021
  273. CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease. Aging Cell. 2019 08; 18(4):e12964.
    View in: PubMed
    Score: 0.021
  274. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A? and TAU proteostasis. Hum Mol Genet. 2019 03 01; 28(5):718-735.
    View in: PubMed
    Score: 0.020
  275. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.020
  276. DNA methylation variability in Alzheimer's disease. Neurobiol Aging. 2019 04; 76:35-44.
    View in: PubMed
    Score: 0.020
  277. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.020
  278. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain. 2018 09 01; 141(9):2721-2739.
    View in: PubMed
    Score: 0.020
  279. Tau Activates Transposable Elements in Alzheimer's Disease. Cell Rep. 2018 06 05; 23(10):2874-2880.
    View in: PubMed
    Score: 0.019
  280. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 04; 14(4):535-562.
    View in: PubMed
    Score: 0.019
  281. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med. 2018 03 29; 10(1):26.
    View in: PubMed
    Score: 0.019
  282. Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson's disease. Brain Pathol. 2018 07; 28(4):560-568.
    View in: PubMed
    Score: 0.019
  283. Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging. 1997 Sep-Oct; 18(5):463-8.
    View in: PubMed
    Score: 0.018
  284. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.018
  285. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.018
  286. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. Antioxid Redox Signal. 2017 Dec 01; 27(16):1269-1280.
    View in: PubMed
    Score: 0.018
  287. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol Psychiatry. 2018 06; 23(6):1521-1529.
    View in: PubMed
    Score: 0.018
  288. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.018
  289. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.018
  290. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.018
  291. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci. 2016 12; 19(12):1569-1582.
    View in: PubMed
    Score: 0.017
  292. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016 11; 19(11):1442-1453.
    View in: PubMed
    Score: 0.017
  293. Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol Psychiatry. 2016 09; 21(9):1158-66.
    View in: PubMed
    Score: 0.017
  294. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One. 2016; 11(7):e0157452.
    View in: PubMed
    Score: 0.017
  295. Response to Letter Regarding Article, "Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Community-Dwelling Older People". Stroke. 2016 06; 47(6):e175.
    View in: PubMed
    Score: 0.017
  296. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
    View in: PubMed
    Score: 0.017
  297. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017 02; 22(2):287-295.
    View in: PubMed
    Score: 0.017
  298. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.016
  299. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people. Circulation. 2015 Jan 13; 131(2):182-9.
    View in: PubMed
    Score: 0.015
  300. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014 Sep; 10(9):e1004606.
    View in: PubMed
    Score: 0.015
  301. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014 03 27; 507(7493):448-54.
    View in: PubMed
    Score: 0.014
  302. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.014
  303. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.013
  304. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012 Jul; 9(6):734-45.
    View in: PubMed
    Score: 0.013
  305. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc. 2011 Jul; 17(4):602-14.
    View in: PubMed
    Score: 0.012
  306. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry. 1990 Nov; 53(11):961-5.
    View in: PubMed
    Score: 0.011
  307. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem. 2010 Oct; 115(1):47-57.
    View in: PubMed
    Score: 0.011
  308. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.009
  309. Biomarker discovery and analysis platform: application to Alzheimer's disease. Biotechniques. 2005 Oct; 39(4):606-7.
    View in: PubMed
    Score: 0.008
  310. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.